Patients Express Gains in Switch to Extended Half-life Therapies

Patients Express Gains in Switch to Extended Half-life Therapies

310822

Patients Express Gains in Switch to Extended Half-life Therapies

For some patients with moderate or severe hemophilia, switching from standard to extended half-life replacement therapy results in improvements in key outcome measures, a study in Canada found. Most of these self-reported gains in health-related quality of life, and physical, mental, and social functioning three months after the switch, however, had dissipated at two years. Still, a majority of the people who began using the extended half-life therapies in this study continued to express a preference…

You must be logged in to read/download the full post.